Remove 2016 Remove Clinical Trials Remove Data
article thumbnail

CDC Seeks Public Comments Regarding Chronic Pain Management

NORML

The call for comments, posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”

article thumbnail

Pain Relief: Marijuana vs. Opioids

CannaMD

In addition, data from the 2017 National Survey on Drug Use and Health showed a potential inverse relationship between marijuana and opioid use, based on data that reported a drop of opioid misuse from 2016 to 2017 (from 11.8 million to 11.4 million to 11.4 Severe Pain: Marijuana Vs. Opioids.

Marijuana 107
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

More than half of prescriptions for medicinal cannabis in Australia given in Queensland, study says

Cannabis Law Report

Medicinal cannabis products such as capsules, creams, oils, lozenges, sprays and granulated flowers were approved for prescription 159,665 times between the start of Australia’s medicinal cannabis program in February 2016 and September 2021, research led by the University of Sydney’s Lambert Initiative for Cannabinoid Therapeutics shows.

article thumbnail

Medical cannabis studies offer hope to opioid users

Healer

In December, Sulak published results of his own 2016 study in which 85 percent of the 525 Integr8 Health patients surveyed reported a decrease or cessation in their opioid use when using medical cannabis. The researchers stressed the need for large, well-designed clinical trials. It remains an open question. “We

article thumbnail

Vice Article: Australians Can Get a Medicinal Cannabis Prescription for Pretty Much Anything

Cannabis Law Report

First academic study of national medicinal cannabis data. Of the 248,000 scripts approved for Australians since inception of national medicinal cannabis scheme in 2016, many related to conditions for which the drug has limited evidence of efficacy, a new University of Sydney study shows. This usage has not been extensively explored.”.

article thumbnail

Debunked: Study Linking Cannabis Use and Metabolic Syndrome

Freedom Leaf

Researchers noted that, for many factors, the data showed “an initial decrease in values but [then an] eventual increase.” Specifically, a 2016 study involving a significantly larger cohort of NHANES participants reported that “current marijuana use is associated with lower odds of metabolic syndrome.”

article thumbnail

Jones Day: The life sciences regulatory regime in Australia

Cannabis Law Report

One such circumstance is a clinical trial. A clinical trial in Australia must have an Australian sponsor (whether it be an individual (e.g., Two of the avenues for supply of UTGs for clinical trials are the Clinical Trial Exemption (CTX) Scheme and the Clinical Trial Notification (CTN) Scheme.